Analysis of TCGA database and immunohistochemical staining results revealed that both mRNA and protein expression levels of CRLF1 were upregulated in ovarian cancer (Fig. S1A–C), with further increases observed following DDP treatment (Figs. S1D, 1E). This evidence concerns the gene CRLF1 and ovarian carcinoma.